Two Biotech Startups to Raise $70m on Wall Street

Bio Blast and Galmed have both filed prospectus with the U.S. Securities and Exchange Commission.

comments Print
Dalia Megiddo and Ehud Gilboa, the founders of the publicly traded drug firm Alcobra Pharma, are planning on floating shares in Bio Blast Pharma, a new biomed startup they formed, for trading on the Nasdaq.
skip all comments

Comments

Sign in to join the conversation.

Required field
Required field

By adding a comment, I agree to this site’s Terms of use

  1. 1